Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares IssuedShares OutstandingShort-Term Debt issuances
Ratios

Aytu Biopharma (AYTU) Short-Term Debt issuances (2021 - 2025)

Historic Short-Term Debt issuances for Aytu Biopharma (AYTU) over the last 5 years, with Q4 2025 value amounting to -$5.8 million.

  • Aytu Biopharma's Short-Term Debt issuances fell 214728.68% to -$5.8 million in Q4 2025 from the same period last year, while for Dec 2025 it was $5.1 million, marking a year-over-year increase of 6955.79%. This contributed to the annual value of $6.7 million for FY2025, which is 70144.23% up from last year.
  • Latest data reveals that Aytu Biopharma reported Short-Term Debt issuances of -$5.8 million as of Q4 2025, which was down 214728.68% from $5.8 million recorded in Q3 2025.
  • Aytu Biopharma's 5-year Short-Term Debt issuances high stood at $42.2 million for Q3 2021, and its period low was -$43.0 million during Q4 2021.
  • Moreover, its 5-year median value for Short-Term Debt issuances was $119500.0 (2022), whereas its average is $63388.9.
  • Its Short-Term Debt issuances has fluctuated over the past 5 years, first tumbled by 216542.06% in 2023, then soared by 98396.4% in 2025.
  • Quarter analysis of 5 years shows Aytu Biopharma's Short-Term Debt issuances stood at -$43.0 million in 2021, then soared by 98.47% to -$658000.0 in 2022, then soared by 71.28% to -$189000.0 in 2023, then crashed by 36.51% to -$258000.0 in 2024, then plummeted by 2147.29% to -$5.8 million in 2025.
  • Its Short-Term Debt issuances stands at -$5.8 million for Q4 2025, versus $5.8 million for Q3 2025 and -$965000.0 for Q2 2025.